Bayer Australia and New Zealand

Bayer’s products and services are designed to benefit people and improve their quality of life. Known worldwide as an inventor company, Bayer continues to strengthen its position through research and innovation.

Divided into three business groups, Bayer HealthCare, Bayer CropScience and Bayer MaterialScience, Bayer employs around 850 people in Australia and New Zealand, and 106,000 people worldwide. In 2007 Bayer generated A$713 million (NZ$812 million) in revenue in Australia and New Zealand.

Bayer Australia and New Zealand is a fully owned subsidiary of Bayer AG based in Leverkusen, Germany. Research and development are key to Bayer’s success and most of today’s business activities are based on Bayer’s own innovations.

Bayer has a competent and committed workforce and upholds the principle of sustainable development, which places corporate social responsibility on an equal level with economic and ecological performance.

Just some of Bayer’s innovations and milestones throughout Australia and New Zealand from 2007:

• Animal Health became the market leader in the companion animal business in Australia and New Zealand.
• There was a successful local integration after Bayer’s global acquisition of Schering AG in 2006.
• The moratoria on the commercialisation of genetically modified canola were lifted in Victoria and New South Wales.
• Cheetah® became the best performing cereal herbicide (in budget achievement) in its first year in tough market conditions.
• Liberty Link® Cotton was launched into the cotton market, making Australia the second country globally to launch a Bayer biotech product in this crop.
• Bridging the gap between rubber and plastic, Desmopan® played a key role in the highly durable and water resistant Dosh Wallet.
• Water based polyurethanes – Bayhydrol® and Bayhydur® – are used to make environmentally friendly surfboards.